GE's Danaher Deal Doesn't Solve Its Problem With Growth
Brooke Sutherland, Bloomberg Opinion industrials columnist, on GE selling its BioPharma business to Danaher for $21.4 billion. Leland Miller, CEO of China Beige Book International, on the progress in ...
25 Feb 201928min
Mueller Report Likely To Impugn The President: Waxman (Podcast)
Seth Waxman, former federal prosecutor and Partner at Dickinson Wright, on the legal issues swirling around the Mueller report, reported to be filed as early as next week. Chris Greiner, CFO of LiveP...
23 Feb 201929min
Facebook Will Have To Rein In Sale Of Data: McNamee (Podcast)
Tech venture capitalist Roger McNamee, Founder of Elevation Partners, discusses his new book, "ZUCKED: Waking Up to the Facebook Catastrophe." Andy Browne, Editorial Director for Bloomberg New Economy...
21 Feb 201929min
EM Optimism Has Been Overblown: Brown Brothers' Thin
Dr. Win Thin, Global Head: Currency Strategy for Brown Brothers Harriman, on the U.S. push for a stable yuan, and his outlook for EM. Danielle DiMartino Booth, CEO of Quill Intelligence LLC, author of...
20 Feb 201926min
Sanders Announces Presidential Run: Greg Valliere
Greg Valliere, chief U.S. policy strategist, AGF Investments, on Senator Bernie Sanders announcing a second White House bid. Burt Flickinger, Managing Director at Strategic Resource Group, discusses W...
19 Feb 201925min
Amazon's Erstwhile NYC Site Will Lure In New Money
Ken Weissenberg, Partner-in-Charge: Real Estate, at EisnerAmper, on how real estate values will react to Amazon backing out of NYC HQ. Anna Edgerton, congressional reporter for Bloomberg, on Trump in...
15 Feb 201929min
Retail Sales Numbers Are Just Wrong: Craig Johnson
Craig Johnson, President of Customer Growth Partners, and Carl Riccadonna, Chief US Economist for Bloomberg Economics, on retail sales posting the worst drop in nine years. Ken DeCubellis, the current...
14 Feb 201925min
Teva's Future Lies In Branded Drugs As Generics Sink (Podcast)
Teva Pharmaceutical’s CEO Kare Schultz discusses the earnings shortfall, product pipeline, and moving into biotech drugs. Matt Rodrigue, Managing Director at Miller Buckfire, a Stifel company, repres...
13 Feb 201929min
